路維光電(688401.SH):目前已實現180nm及以上製程節點半導體掩膜版量產
格隆匯9月22日丨路維光電(688401.SH)在接受調研時表示,目前公司已實現180nm及以上製程節點半導體掩膜版量產,滿足先進半導體芯片封裝、半導體器件、先進指紋模組封裝、高精度藍寶石襯底(PSS)等產品應用。公司通過自主研發,儲備了150nm節點半導體掩膜版製造核心技術,同時公司已掌握的半導體掩膜版製造技術可以覆蓋第三代半導體相關產品,為我國半導體行業的發展提供關鍵的上游材料國產化配套支持。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.